Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Zekri J"'
Publikováno v:
Journal of Multidisciplinary Healthcare, Vol 2015, Iss default, Pp 335-344 (2015)
Jamal Zekri,1 Lydia M Dreosti,2 Marwan Ghosn,3 Emad Hamada,4 Mohamed Jaloudi,5 Ola Khorshid,6 Blaha Larbaoui7 1College of Medicine, King Faisal Specialist Hospital and Research Centre, Alfaisal University, Jeddah, Saudi Arabia; 2Department of Medical
Externí odkaz:
https://doaj.org/article/35851388e0564f4e9e2728f2692390a9
Publikováno v:
Libyan Journal of Medicine, Vol 3, Iss 4, p AOP:080825 (2008)
The health service involves a spectrum of personnel working together towards achieving a common goal, namely the delivery of high quality health care. This involves a large volume of communication between members of staff and patients and their relat
Externí odkaz:
https://doaj.org/article/ab3b2503bce644d5a04e88ff05df5059
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Annals of Oncology June 2016 27 Supplement 2:ii88-ii88
Autor:
Zekri J, M Al-Foheidi, M Mokhtar, M Mansour, M Mahrous, Syed Mustafa Karim, Al-Rehaily S, Darwish T, A Rizvi
Publikováno v:
Experimental Oncology. 37:146-150
Background: Lapatinib alone or in combination with other agents, mostly capecitabine is used for patients with advanced/metastatic HER2 positive breast cancer (HER2+BC) after progression on trastuzumab based therapy. Here we report our experience wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9573829b4aed07f4aaa0ff4c2d306d27
https://doi.org/10.31768/2312-8852.2015.37(2):146-150
https://doi.org/10.31768/2312-8852.2015.37(2):146-150
Autor:
Shereef Elsamany, Zekri J, Al-Shehri A, Al Zahrani A, El Taani H, M Mahrous, Jaudah Al-Maghrabi, Bassi S, Al-Rehaily S, Darwish T, Sadiq Bb
Publikováno v:
Genetics and Molecular Research. 16
Mutations in codons 12/13 of K-ras exon 2 are associated with reduced benefit from anti-epidermal growth factor receptor antibody treatment for metastatic colorectal cancer (CRC). Here, we evaluated the frequency of K-ras mutations and their relation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f9e273e68b84e7a942516057800dbe
https://doi.org/10.4238/gmr16019369
https://doi.org/10.4238/gmr16019369
Autor:
Zekri, J. M.1 jmzekri@hotmail.com, Ibrahim, E.1, Ben Sadiq, B.2, Al-Gahmi, A. M.1, Zeeneldin, A. A.1, Elkhodary, T. R.1, Gaballa, H. E.1, Fawzy, E. E.1, Elsayed, M. E.1, Bahadur, Y.1, Awadalla, S.2, Alzahran, M. S.2
Publikováno v:
Ecancermedicalscience. 2010, Vol. 4, p1-9. 9p. 2 Charts, 2 Graphs.
Publikováno v:
British Journal of Cancer. 5/6/2003, Vol. 88 Issue 9, p1335-1338. 4p.
Autor:
Abdel-Ghany Em, Zekri J
Publikováno v:
Journal of Cancer Research & Therapy, Vol 1, Iss 10, Pp 226-229 (2013)
Cutaneous side effects of capecitabine include hand foot syndrome which manifests as erythema, swelling and/or desquamation. We report a case on capecitabine treatment presenting with unusual hyperpigmentation of the tongue and skin of the palms and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::100a88775756c8de3381e1aa9e3f3967
https://doi.org/10.14312/2052-4994.2013-34
https://doi.org/10.14312/2052-4994.2013-34
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.